Ozanimod: a better or just another S1P receptor modulator?

Lancet Neurol. 2016 Apr;15(4):345-7. doi: 10.1016/S1474-4422(16)00041-7. Epub 2016 Feb 12.
No abstract available

Publication types

  • Comment

MeSH terms

  • Female
  • Humans
  • Immunologic Factors / pharmacology*
  • Indans / pharmacology*
  • Male
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*
  • Outcome Assessment, Health Care*
  • Oxadiazoles / pharmacology*
  • Receptors, Lysosphingolipid / drug effects*

Substances

  • Immunologic Factors
  • Indans
  • Oxadiazoles
  • Receptors, Lysosphingolipid